Atlas Trials

Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line

Clinical trial NCT01567904 · TERMINATED

Trial details

NCT number
NCT01567904
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL)
Start date
2012-05-01
Primary completion
2012-07-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.